Dr. Raymond Cross of Mercy Medical Center joins Jennifer Franciotti for a conversation about ulcerative colitis - how it ...

SPRING HOUSE, PA – Johnson & Johnson (NYSE: JNJ) has submitted a supplemental Biologics License Application (sBLA) to the U.S ...

Crohn’s and colitis - During Crohn’s and Colitis Awareness Week, organisations from all over the globe come together to raise ...

Understanding current trends in the incidence, prevalence, and distribution of ulcerative colitis can help inform diagnosis and treatment. Most incidence and prevalence studies for UC show males and ...

The causes of ulcerative colitis aren't quite known, but women of child-bearing age should be especially vigilant for ...

The American Gastroenterological Association (AGA) has released a new clinical guideline on the pharmacological management of ...

5. The guidance recommends advanced or immunomodulatory therapy after failure of 5-aminosalicylates instead of a "step-up" approach. The recommendations also define moderate to severe disease using a ...

Clinical trials are necessary for finding new ways of preventing, detecting or treating diseases, but often, limited ...

Palatin Announces Completion of Patient Enrollment in Phase 2 Study of Orally Administered Melanocortin Agonist PL8177 in Ulcerative Colitis ...

During Crohn's and Colitis Awareness Week from December 1, organisations from all over the globe come together to raise vital ...

Johnson & Johnson has announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and ...